Trading-Stocks.de

Normale Version: Novus Therapeutics
Du siehst gerade eine vereinfachte Darstellung unserer Inhalte. Normale Ansicht mit richtiger Formatierung.
Healthcare | Biotechnology | USA
Novus Therapeutics Advances OP0201 Development Program Across Several Clinical Trials

Screening Initiated for Phase 1 Pharmacodynamic Effects Trial (Study C-001)

Screening Initiated for Second Cohort of Phase 1 Trial in Healthy Adults (Study C-002)

Enrollment Completed in Phase 1 Trial in Adults with Acute Otitis Media (Study C-004)

New Phase 2a Trial in Infants and Children with Acute Otitis Media Planned for 2019 (Study C-006)

...

NVUS heute + 41% ...

[Bild: NVUSc1dl1715.png]